Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4

Espen Aberg1, Maria Perander, Bjarne Johansen

  • 1Department of Pharmacology, Institute of Medical Biology, University of Tromsø, N-9037 Tromsø, Norway, and Cancer Research UK Stress Response Laboratory, Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee, UK.

Insights

MAPK-activated protein kinase 5 (MK5) is regulated by both ERK3 and ERK4. These atypical MAPKs phosphorylate and activate MK5, influencing its stability and cellular localization.

Area of Science:

  • Cellular signaling pathways
  • Protein kinase regulation
  • Mitogen-activated protein kinases (MAPKs)

Background:

  • MAPK-activated protein kinase 5 (MK5) is a known substrate of the atypical MAPK ERK3.
  • ERK3 binding to MK5 leads to MK5 activation, ERK3 stabilization, and nuclear exclusion of both proteins.
  • ERK3 ablation partially reduces MK5 activity, indicating other regulatory mechanisms.

Purpose of the Study:

  • To identify additional physiological regulators of MK5 activity.
  • To investigate the role of ERK4, an ERK3-related kinase, in MK5 regulation.

Main Methods:

  • Small interfering RNA (siRNA) mediated knockdown of ERK3 and ERK4 in HeLa cells.
  • Analysis of endogenous MK5 activity and protein levels.
  • Co-immunoprecipitation assays to assess protein-protein interactions.
  • Studies using fibroblasts from ERK3 null mice.

Main Results:

  • ERK4 directly interacts with MK5, leading to MK5 phosphorylation and activation.
  • ERK4 binding causes MK5 relocalization from the nucleus to the cytoplasm.
  • Knockdown of ERK4 alone reduces MK5 activity by approximately 50%.
  • Combined knockdown of ERK3 and ERK4 reduces MK5 activity by over 80%.

Conclusions:

  • MK5 activation is dependent on both ERK3 and ERK4.
  • ERK3 and ERK4 act as physiological regulators of MK5 activity.
  • These findings reveal a dual MAPK regulatory mechanism for MK5.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...